Cancer is a major public health problem worldwide. According to the WHO, Oman is experiencing almost double the incidence of cancer. CrossScope DX, a workflow integrated vendor-anonymous digital pathology platform designed with advanced workflow features, integrated and highly flexible workflow solutions, open and scalable architectures, so-called endologies for pathologists, and workloads for pathologists. Offered. Reduces turnaround time, ensures a quick diagnosis and therefore helps reduce the disease burden in the region.
With this partnership, Walid Pharmacy will be the official representative of Croscope in the Oman region. Both organizations intend to bring state-of-the-art comprehensive digital pathology platform, AI and ML tools to cancer diagnosis service providers. They will also explore all possible avenues for collaboration, work together and learn about each other’s skills, networks and how to improve the cancer diagnostics landscape in the region.
“We are delighted to be joining forces with Walid Pharmacy Group. Walid Pharmacy’s experienced team has a proven track record of delivering and utilizing healthcare IT solutions in the Oman region and represents a full partner for CrossScope. By teaming up, we are confident that we have created the synergy to accelerate the growth and commercialization of our digital pathology workflow. ” Said Dr. Jayendra Shinde, CEO, CrossScope.
CrossScope also intends to work with reputable hospitals, clinical institutes, diagnostic chains, R&D labs, research institutes, pharma companies and other organizations in related fields with leading opinion leaders in the field where the company’s products bring clinical value to consumers. .
